The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy

2020 
We retrospectively analyzed treatment patterns and healthcare costs among patients diagnosed with diffuse large B-cell lymphoma (DLBCL) during each line of therapy (LOT) using data from the IBM® Ma...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    26
    References
    2
    Citations
    NaN
    KQI
    []